These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 26355118)
1. Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus. Murphy A; Shamshirsaz A; Markovic D; Ostlund R; Koos B Reprod Sci; 2016 Mar; 23(3):365-71. PubMed ID: 26355118 [TBL] [Abstract][Full Text] [Related]
2. The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial. Celentano C; Matarrelli B; Pavone G; Vitacolonna E; Mattei PA; Berghella V; Liberati M J Matern Fetal Neonatal Med; 2020 Mar; 33(5):743-751. PubMed ID: 30558466 [No Abstract] [Full Text] [Related]
3. The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol. Chang HH; Choong B; Phillips AR; Loomes KM Exp Biol Med (Maywood); 2015 Jan; 240(1):8-14. PubMed ID: 25060739 [TBL] [Abstract][Full Text] [Related]
4. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. Scioscia M; Gumaa K; Selvaggi LE; Rodeck CH; Rademacher TW J Perinat Med; 2009; 37(5):469-71. PubMed ID: 19492925 [TBL] [Abstract][Full Text] [Related]
5. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Scioscia M; Kunjara S; Gumaa K; Gomez Galan AM; McLean P; Rodeck CH; Rademacher TW Gynecol Obstet Invest; 2007; 64(4):217-23. PubMed ID: 17664885 [TBL] [Abstract][Full Text] [Related]
7. Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat. Kawa JM; Przybylski R; Taylor CG Exp Biol Med (Maywood); 2003 Sep; 228(8):907-14. PubMed ID: 12968062 [TBL] [Abstract][Full Text] [Related]
8. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial. Fraticelli F; Celentano C; Zecca IA; Di Vieste G; Pintaudi B; Liberati M; Franzago M; Di Nicola M; Vitacolonna E Acta Diabetol; 2018 Aug; 55(8):805-812. PubMed ID: 29774465 [TBL] [Abstract][Full Text] [Related]
9. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people. Campbell WW; Ostlund RE; Joseph LJ; Farrell PA; Evans WJ Horm Metab Res; 2001 Jan; 33(1):44-51. PubMed ID: 11280715 [TBL] [Abstract][Full Text] [Related]
11. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Croze ML; Soulage CO Biochimie; 2013 Oct; 95(10):1811-27. PubMed ID: 23764390 [TBL] [Abstract][Full Text] [Related]
12. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Matarrelli B; Vitacolonna E; D'Angelo M; Pavone G; Mattei PA; Liberati M; Celentano C J Matern Fetal Neonatal Med; 2013 Jul; 26(10):967-72. PubMed ID: 23327487 [TBL] [Abstract][Full Text] [Related]
13. D-chiro-inositol metabolism in diabetes mellitus. Ostlund RE; McGill JB; Herskowitz I; Kipnis DM; Santiago JV; Sherman WR Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9988-92. PubMed ID: 8234346 [TBL] [Abstract][Full Text] [Related]
14. Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients. Jung TS; Hahm JR; Kim JJ; Jung JH; Kang MY; Moon SW; Lee KW; Kim HC; Lee JD; Kim JH; Kim DR; Chung SI Yonsei Med J; 2005 Aug; 46(4):532-8. PubMed ID: 16127779 [TBL] [Abstract][Full Text] [Related]
15. The role of inositols during pregnancies complicated by gestational diabetes mellitus: a narrative review. Mazzera I; Graziano A; Vizzielli G; Driul L Gynecol Endocrinol; 2024 Dec; 40(1):2411727. PubMed ID: 39364801 [TBL] [Abstract][Full Text] [Related]
16. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442 [TBL] [Abstract][Full Text] [Related]
17. Inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: now and the future. Laganà AS; Myers SH; Forte G; Naem A; Krentel H; Allahqoli L; Alkatout I; Unfer V Expert Opin Drug Metab Toxicol; 2024; 20(1-2):61-72. PubMed ID: 38226638 [TBL] [Abstract][Full Text] [Related]
18. Optimization and validation of a chiral GC-MS method for the determination of free D-amino acids ratio in human urine: application to a gestational diabetes mellitus study. Lorenzo MP; Dudzik D; Varas E; Gibellini M; Skotnicki M; Zorawski M; Zarzycki W; Pellati F; García A J Pharm Biomed Anal; 2015 Mar; 107():480-7. PubMed ID: 25679092 [TBL] [Abstract][Full Text] [Related]
19. Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension. Santamaria A; Corrado F; Baviera G; Carlomagno G; Unfer V; D'anna R J Matern Fetal Neonatal Med; 2016; 29(14):2245-7. PubMed ID: 26364618 [TBL] [Abstract][Full Text] [Related]
20. Inositol phosphoglycan P-type in preeclampsia: a novel marker? Williams PJ; Gumaa K; Scioscia M; Redman CW; Rademacher TW Hypertension; 2007 Jan; 49(1):84-9. PubMed ID: 17116762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]